Genomics Research Tools
Future GSI Support for Genomics Research Tools with broad use by the BUMC community.
The BUMC GSI will be looking for feedback and suggestions for new tools that are both affordable and have broad utility to the genomics community. If you have an idea of a cost-effective genomics package, please discuss with GSI Co-Directors how we can partner to explore new support options to help labs enter into the genomics research arena. You may submit your suggestions via email to firstname.lastname@example.org.
The GSI has a limited number of seats for the GraphPad Prism
software. The use of this software is completely subsidized by the GSI and thus is complementary to use by the BUMC community. Since there is a limited number of seats, claiming an account will be on a first-come-first-serve basis. To be added to this account, please email email@example.com
requesting access, pending an available seat.
Ingenuity IPA Software – 2020 Important Update
*Updated April 20, 2020
Qiagen Contact: Emilie Kollias – QIAGEN <Emilie.Kollias@qiagen.com> or Scott Magin – QIAGEN <Scott.Magin@qiagen.com> to ask for instructions.
From this April 2020 to March 2021, GSI will continue to maintain the current IPA license structure with only a Limited Number of Power User accounts on a limited basis to maximize usage. If you are interested in a Power User account or are interested in the status of your account, please contact us at firstname.lastname@example.org. Power Users must provide an account number to the GSI for a $300 buy-in charge (similar to a co-pay) to set up your account and password. As a Power User, you will also help GSI manage this account and arrange for re-upload of your data.
If you are a current Power User seat holder on IPA please be aware that your ‘seat’ can only be registered on 3 unique devices and these credentials cannot be distributed throughout your lab! If you have personnel in your labs wanting to try out IPA or you are just interested in trying out IPA, you can register for a trial account here. Please don’t hesitate to reach out to us at GSI@bu.edu with any additional questions.
The GSI recently renewed its license to Qiagen’s Ingenuity Pathway Analysis (IPA) platform with the renewal extending through February, 2021. However, in a letter sent to the BU community on Friday, President Robert A. Brown described an anticipated $52 million budget shortfall in the spring semester precipitated by the coronavirus pandemic.
As a result, we anticipate that the GSI’s operating budget will be affected in the coming fiscal year limiting our ability to support the GSI community as we have done in the past. We know many of you rely on IPA analysis and continue to explore IPA analysis for your research, but there is a tremendous cost associated with this license and the uncertainty of the GSI budget may force us to terminate our contract with IPA in March of 2021. Thus, we are encouraging the GSI community to make the most out of the IPA platform over the coming year while the IPA license is active. We appreciate your patience and understanding during this time of great uncertainty.
The cost for Ingenuity IPA has continued rising ~6% each year since GSI began paying for this initiative in 2010. Two prominent Med Schools have already discontinued their Ingenuity IPA programs, while other Cores are charging ~$3000 per user.
This current plan is still providing each Power User a huge subsidy in cost (>$12K), and this is the only way GSI can currently afford to sustain the IPA initiative for the BU/BUMC community. We appreciate your patience and assistance as we handle new challenges and transitions this year.
For additional details and inquiries about this new program, please email email@example.com.